AMGN
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Amgen reports positive topline Phase 3 results for dazodalibep in moderate-to-severe systemic Sjögren's diseaseSep 22, 2026
- Amgen's Imdelltra combined with AstraZeneca's Imfinzi improved survival versus Imfinzi alone as first-line maintenance therapy in ES-SCLCSep 9, 2026
- TEZSPIRE demonstrated positive Phase 3 results in eosinophilic esophagitis, meeting both co-primary and all key secondary endpointsAug 27, 2026
- Amgen and Zai Lab announced a global collaboration to evaluate a DLL3 ADC in combination therapyApr 1, 2026
- FDA grants full approval to Amgen's Imdelltra® in extensive stage small cell lung cancerNov 20, 2025